Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
169M
-
Shares change
-
+23M
-
Total reported value, excl. options
-
$1.2B
-
Value change
-
+$168M
-
Put/Call ratio
-
0.9
-
Number of buys
-
70
-
Number of sells
-
-58
-
Price
-
$7.13
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q1 2017
172 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q1 2017.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 169M shares
of 309M outstanding shares and own 54.68% of the company stock.
Largest 10 shareholders include FMR LLC (20.7M shares), PERCEPTIVE ADVISORS LLC (17.3M shares), BlackRock Inc. (12M shares), Redmile Group, LLC (11.4M shares), JENNISON ASSOCIATES LLC (9.04M shares), VANGUARD GROUP INC (8.69M shares), Palo Alto Investors, LLC (7.88M shares), JANUS CAPITAL MANAGEMENT LLC (7.14M shares), MORGAN STANLEY (6.13M shares), and STATE STREET CORP (5.77M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.